TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Main Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Commentary
Opinionated Stock Takes
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
CommunityDashboard
Log inCreate Account
← Back to TickerSpark
▌IPO·August 12, 2026

Pelican Acquisition II Corporation Right IPO: What Investors Need to Know

Pelican Acquisition II Corporation Right (NASDAQ: PLCIR) is expected to list on 2026-08-12, but the price range has not been disclosed yet. This is a SPAC/right offering, not an operating company IPO, so the key question is whether the sponsor can source a credible technology deal. Watch the trust structure and dilution; the setup favors investors who are comfortable underwriting a blank-check search process.

IPOIPONASDAQPLCIR
By TickerSpark·August 12, 2026·5 min read
Pelican Acquisition II Corporation Right IPO: What Investors Need to Know
▌Key Takeaway
Pelican Acquisition II Corporation Right (NASDAQ: PLCIR) is expected to list on 2026-08-12, but the price range has not been disclosed yet. This is a SPAC/right offering, not an operating company IPO, so the key question is whether the sponsor can source a credible technology deal. Watch the trust structure and dilution; the setup favors investors who are comfortable underwriting a blank-check search process.

Quick Facts

Expected listing date: August 12, 2026

Exchange: NASDAQ

Proposed symbol: PLCIR

Status: Expected

Company Overview

Pelican Acquisition II Corporation Right is tied to Pelican Acquisition II Corporation, a blank check company formed to complete a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination. The company says it is not limited to any one industry, but it intends to primarily focus on technology targets globally. It was incorporated in the Cayman Islands on February 26, 2026, and its principal executive offices are in New York.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

This is not an operating business with products, customers, or revenue. The IPO is structured as units, with each unit consisting of one ordinary share plus one right. Each right entitles the holder to receive 1/10 of one ordinary share when an initial business combination is completed. The filing says up to 8,625,000 units may be sold, including the underwriters’ over-allotment option. In broader market terms, this is part of the SPAC segment, where the real investment case depends on the eventual target rather than the shell company itself. That makes the technology focus important: the company is trying to position itself in a sector that still attracts capital, but it will need a compelling acquisition to stand out from a crowded field of blank-check vehicles.

Why They're Going Public

The stated purpose of the offering is to raise capital for a future business combination and to fund the SPAC’s search process. The filing estimates gross IPO proceeds of $75.0 million, or $86.25 million if the over-allotment is fully exercised, plus $3.865 million to $4.2025 million from the private placement. Most of the capital is intended to sit in trust, with $75.75 million to $87.1125 million held there.

The company says the $960,000 kept outside the trust will cover working capital and offering-related needs, including a $270,000 sponsor administrative fee for 21 months and $40,000 in working capital/reserves. In practical terms, going public gives the sponsor a funded runway to identify and negotiate a deal, but it does not yet create an operating platform. The value creation step comes only if management can complete a business combination within the 21-month window.

Get AI research on any stock

Instant reports, daily intelligence, and an AI analyst in your pocket.

Get Started →

Financial Highlights

There is no operating revenue trend to analyze because the company has not yet started operations. The S-1 says it has neither engaged in any operations nor generated any revenues to date, and it will not generate operating revenues until after a business combination. As of February 28, 2026, the company had $0 in cash and a working capital deficit of $4,141.

The audited financial statements cover only the period from February 26, 2026, through February 28, 2026, which underscores how early-stage this vehicle is. The auditor included a going concern warning because of the limited cash position and working capital deficit. There is no year-over-year growth, no gross margin, and no cash flow history to evaluate at this stage. For investors, the financial profile is essentially a pre-operating shell backed by trust proceeds rather than a business with recurring economics.

Risk Factors

The biggest risk is simple: the company may never complete a business combination within the 21-month period. If that happens, it must liquidate and redeem public shares. That makes this a time-sensitive search process, not a traditional operating-company IPO. Investors are also taking dilution and redemption risk typical of SPAC structures, where public holders can be diluted by sponsor economics and other issuance mechanics.

There are also execution and target-quality risks. The company may pursue a foreign target, which can add legal, regulatory, and disclosure complexity. It may also target an early-stage, financially unstable, or low-cash-flow business, which would raise volatility after a deal closes. The sponsor’s background and network matter here, but the filing still leaves shareholders dependent on an acquisition that has not yet been identified.

Comparable Public Companies

There are no true operating-company comparables because Pelican Acquisition II Corporation Right is a blank-check vehicle. The closest public peers are other SPACs, since the economics are driven by trust value, sponsor structure, and the eventual acquisition path rather than current revenue. In that sense, the relevant comparison set is broader SPAC issuance rather than a single industry peer group.

Because the company has no operating revenue, standard valuation metrics like P/E and P/S do not apply. For market context, the broader SPAC window appears open but selective: 2026 coverage noted that SPACs have regained footing and that 107 SPACs had listed in the U.S. through June 15, 2026, versus 57 in the same period a year earlier. That suggests the category is back in favor relative to the prior slump, but investors are still likely to demand a credible target and clean structure before assigning much premium. No direct public operating comps were identified in the filing materials, so there are no meaningful trading multiples to anchor against here.

Verdict

The main thing to watch as Pelican Acquisition II Corporation Right prices is not operating performance, but structure: how much capital lands in trust, how much is left outside trust, and how much dilution comes with the sponsor and private units. The filing points to $75.75 million to $87.1125 million in trust and $960,000 outside it, which is a fairly standard SPAC setup, but the real test will be whether management can identify a technology deal that justifies the vehicle. Shareholders should watch the 21-month deadline closely, because the downside case is liquidation if no business combination gets done.

The timing angle is that the SPAC market has reopened enough for new listings, and technology remains a narrative that can still attract attention. That makes this IPO noteworthy now: it is a technology-focused blank-check vehicle entering a market where SPAC issuance has revived, but investor appetite is still highly selective. The setup favors investors who are comfortable underwriting a sponsor-led search process and waiting for the eventual target rather than buying into a proven business today.

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌For Active Investors

Don't trade alone.

Get market intelligence delivered daily.

Get Full Access →

Not ready to subscribe? ·

▌For Active Investors

Stock research for every investor

  • Reports on any stock
  • Daily market intelligence
  • AI analyst in your pocket
  • Portfolio analysis tools
Get Full Access →

Cancel anytime

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌Keep reading

More to read

All articles
Inside the Northern Lights Fund Trust III IPO: Setup and Risks
HAWG

Inside the Northern Lights Fund Trust III IPO: Setup and Risks

Northern Lights Fund Trust III is expected to list on the NYSE on 2026-08-14, but the price range has not been disclosed. The filing set does not show a traditional operating-company IPO; it points to an existing Delaware statutory trust used to launch and administer funds. Watch whether investors treat this as a fund-platform story or pass until there is clearer pricing and a specific series-level catalyst.

Aug 13·5 min
Gores Holdings XI IPO: The Bull and Bear Case
GHXI

Gores Holdings XI IPO: The Bull and Bear Case

Gores Holdings XI, Inc. Class A Ordinary Shares (NASDAQ: GHXI) is expected to list on 2026-08-13, but the price range has not been disclosed. This is a SPAC, so the real question is not near-term revenue — it is whether the Gores team can source a strong deal before dilution and redemption risk bite.

Aug 12·5 min
Vogenx Inc IPO Preview: Metabolic Biotech Meets Cash Runway Risk
VOGX

Vogenx Inc IPO Preview: Metabolic Biotech Meets Cash Runway Risk

Vogenx Inc Common Stock is expected to list on NASDAQ on 2026-08-12, but the price range has not been disclosed. The company is a clinical-stage biopharma name focused on metabolic disorders, including post-bariatric hypoglycemia and gastroparesis. The setup favors investors who want an early-stage catalyst story, but shareholders should watch the capital needs and clinical risk closely.

Aug 12·5 min